Gregory R. Jackson, Ph.D., Joins Life Sciences Greenhouse Investments
Harrisburg, PA - Life Sciences Greenhouse Investments (www.LSGPA.com) is pleased to announce that Gregory R. Jackson, Ph.D., will be joining the organization on June 1st. Greg will serve as Executive Vice President. Among his responsibilities will be identification of new investment opportunities and conducting due diligence, as well as mentoring and monitoring performance of portfolio companies.
Greg was Co-Founder and Chief Technology Officer of MacuLogix, Inc., an ophthalmic medical device company that was acquired by LumiThera, Inc., in 2022. Dr. Jackson has a total of 19 years’ experience in the medical device industry.
“Greg’s experience as a Founder, CSO and academic researcher combine to make him exceptionally well-qualified for the role of Executive Vice President,” said LSG Investments President & CEO, Michele Washko. We are excited about the fresh perspective and unique knowledge base that he’ll be bringing to the organization.
Prior to co-founding MacuLogix, Greg spent 15 years in academic medical research, most recently as an Associate Professor of Ophthalmology at Penn State College of Medicine from 2007 to 2014. Greg began his academic career as an Assistant Professor of Ophthalmology at the University of Alabama at Birmingham.
Dr. Jackson holds a Bachelor of Science degree from Clarion University of Pennsylvania, and a Ph.D. from the University of Alabama at Birmingham.
About Life Sciences Greenhouse Investments
Life Sciences Greenhouse Investments provides funding and targeted business advice to help startup life science companies bring life-changing technologies to market. By providing early-stage capital and operational expertise to innovative technologies, fostering company growth, and creating jobs, LSG Investments is strengthening Pennsylvania’s vibrant life sciences ecosystem and improving healthcare outcomes for patients around the world.
Since LSG Investments was founded in 2002 as Life Sciences Greenhouse of Central PA, the evergreen venture fund has invested $37 million into 72 companies and projects that collectively have created and retained 8,500 direct and indirect jobs in the Commonwealth. Today, more than 152 products developed by LSG Investment-funded companies are currently marketed or in development.
# # #
CONTACT: info@LSGPA.com
717-929-8729